MyMD Pharmaceuticals Inc (MYMD)

[critical_perspective]

The primary target for Telomir -- age reversal -- just so happens to align with MYMD's primary target of sarcopenia. Coincidence? I haven't been able to see the actual makeup of Telomir-1 but, like you, I suspect its development is directly linked to the research done for MYMD-1. Why haven't the full results from the sarcopenia study (which ended early June 2023) been published yet? The Annual Report just came out the other day and it does not inspire confidence. Actually, from what I can make of it, it looks quite disappointing... especially with the departure of key individuals. In addition, the lack of communication from the company is disturbing, and in light of everything else, rather alarming.

For those of us who were invested in Williams' previous ventures (i.e. Star Scientific, Rock Creek), this behavior of questionable actions (to say the least) unfortunately appears to be his M.O. He found a compelling means of raising significant capital and then leaving investors dry. I don't have a good feeling about any of it. It is indeed very unfortunate, because the product(s) and the research behind them were truly promising and significant!